Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
FENNEC PHARMACEUTICALS INC. (FENC)
Standardized SEC financial data for FENNEC PHARMACEUTICALS INC. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001211583 · NASDAQ · Biological Products, (No Diagnostic Substances).
Gross margin
44.8%
Operating margin
-14.1%
Net margin
-21.8%
Revenue growth (YoY)
-6.1%
Return on equity
-27.5%
ROIC
-27.5%
Free cash flow
-$12.5M
Debt / equity
0.55×
Ratios for fiscal year 2025, standardized from SEC filings.